Deep, focused next-generation sequencing has disclosed that subclonal mutations (i.e., those present in only a portion of tumor cells) could be detected for all driver genes and are linked to immediate disease progression and poor result.11–thirteen This is particularly pertinent for TP53 Transformed DLBCL regularly increase CDKN2A deletions and MYC https://branchy098jyn4.oneworldwiki.com/user